ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 157 filers reported holding ANIKA THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,510,000 | +25.0% | 27,512 | -7.5% | 0.01% | +33.3% |
Q2 2019 | $1,208,000 | +166.7% | 29,735 | +254.1% | 0.01% | +200.0% |
Q4 2017 | $453,000 | -7.0% | 8,398 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $487,000 | +12.5% | 8,398 | -5.1% | 0.00% | 0.0% |
Q4 2016 | $433,000 | +0.9% | 8,849 | -1.3% | 0.00% | -25.0% |
Q3 2016 | $429,000 | -19.8% | 8,965 | -36.0% | 0.00% | -20.0% |
Q4 2015 | $535,000 | -88.0% | 14,012 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $4,460,000 | +920.6% | 14,012 | +5.9% | 0.01% | +25.0% |
Q2 2015 | $437,000 | -18.5% | 13,234 | +1.6% | 0.00% | 0.0% |
Q1 2015 | $536,000 | +4.3% | 13,028 | +3.2% | 0.00% | 0.0% |
Q4 2014 | $514,000 | -2.7% | 12,624 | -12.4% | 0.00% | 0.0% |
Q3 2014 | $528,000 | -17.6% | 14,416 | +4.2% | 0.00% | -33.3% |
Q2 2014 | $641,000 | +15.7% | 13,836 | +2.6% | 0.01% | +20.0% |
Q1 2014 | $554,000 | -18.4% | 13,484 | -33.9% | 0.01% | -28.6% |
Q4 2013 | $679,000 | +169.4% | 20,406 | +93.8% | 0.01% | +133.3% |
Q3 2013 | $252,000 | – | 10,528 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Caligan Partners LP | 1,081,360 | $20,145,737 | 9.25% |
Trigran Investments, Inc. | 2,217,019 | $41,303,065 | 4.40% |
DIKER MANAGEMENT LLC | 50,239 | $935,953 | 0.84% |
Virtus Investment Advisers, Inc. | 45,579 | $849,137 | 0.58% |
Virtus Fund Advisers, LLC | 3,490 | $65,019 | 0.46% |
CAPITAL MANAGEMENT CORP /VA | 84,225 | $1,569,112 | 0.35% |
Riverwater Partners LLC | 17,597 | $327,832 | 0.30% |
BOOTHBAY FUND MANAGEMENT, LLC | 617,602 | $11,505,925 | 0.27% |
XTX Topco Ltd | 28,033 | $522,255 | 0.09% |
GSA CAPITAL PARTNERS LLP | 51,638 | $962 | 0.08% |